Solid biosciences announces appointment of ian f. smith as chairman of the board of directors

Cambridge, mass., june 18, 2020 (globe newswire) -- solid biosciences inc. (nasdaq: sldb), a life sciences company focused on advancing meaningful therapies for duchenne muscular dystrophy, announced today the appointment of board member ian f. smith as chairman of the board. mr. smith succeeds andrey zarur, ph.d., who served as chairman of the board since 2013 and is one of the co-founders of solid biosciences. the appointment is effective june 16, 2020.
SLDB Ratings Summary
SLDB Quant Ranking